Treatment Comparison
9 min read

Arthritis Stem Cell Therapy vs Immunosuppressive DMARDs — Honest Comparison

Revisado médicamente por Equipo Médico SCL
Share:
Summarize with AI:

When facing rheumatoid arthritis & inflammatory arthritis, patients often weigh stem cell therapy against immunosuppressive dmards. Both have valid clinical applications, and the best choice depends on your specific condition, disease stage, and personal goals. Here's an evidence-based comparison to help you make an informed decision.

Comparison at a Glance

FactorStem Cell TherapyImmunosuppressive DMARDs
InvasivenessMinimally invasive (injection/infusion)Varies — often invasive or chronic medication
Recovery Time2–5 daysWeeks to months (surgery) or ongoing (medication)
ApproachTargets root cause (cellular repair)Symptom management or structural replacement
Side EffectsMild, temporaryCan be significant (surgical complications, drug side effects)
RepeatableYes, safelyRevision surgery is complex; medications have cumulative effects
Cost (Turkey)€6,000–€10,000Varies widely by country and intervention

Key Advantages of Stem Cell Therapy

MSC therapy modulates the immune system naturally; DMARDs suppress it artificially
Stem cells do not increase infection risk; DMARDs significantly increase susceptibility to infections
No liver/kidney toxicity with MSCs; methotrexate requires regular organ function monitoring
MSC therapy promotes tissue repair; DMARDs only slow joint destruction
Periodic treatment (every 12–18 months) vs daily/weekly medication with cumulative side effects
Can be combined with reduced-dose conventional medications for optimal outcomes

When Immunosuppressive DMARDs May Be More Appropriate

We believe in honest, patient-first guidance. There are situations where immunosuppressive dmards may be the better option:

End-stage disease where tissue damage is too extensive for regenerative repair
Emergency situations requiring immediate intervention
Cases where published evidence strongly favors conventional treatment for your specific disease stage
When conventional treatment has a proven long-term track record for your exact condition profile

The Combination Approach

Best of Both Worlds

In many cases, the optimal approach is a combination strategy: using stem cell therapy alongside optimized conventional treatment. MSC therapy can enhance the effectiveness of existing treatments, reduce medication dosage requirements, and address aspects of the disease that conventional treatments cannot target (tissue repair, immune modulation, neuroprotection).

Making Your Decision

Step 1

Share your medical records with our team for a free evaluation of your candidacy

Step 2

Receive an honest assessment comparing your options — including when stem cells may NOT be the best choice

Step 3

Make an informed decision based on evidence, not marketing — with our medical team's guidance

Preguntas frecuentes

Biologic DMARDs (Humira, Enbrel, Remicade) suppress specific immune pathways to reduce inflammation. MSC therapy modulates the immune system more broadly while also promoting tissue repair. Biologics carry risks of serious infections and malignancy; MSCs have minimal side effects. Many rheumatologists see value in combining approaches.

Get an Honest Assessment

Not sure which approach is right for your arthritis condition? Our medical team will review your case and provide a transparent recommendation — even if stem cell therapy isn't the best option for you.

Medical Disclaimer: This comparison is based on published clinical literature and is provided for informational purposes. Individual outcomes vary. This content does not constitute medical advice. Consult with qualified healthcare professionals before making treatment decisions. StemCell Longevita operates as an international patient coordination platform.